The potential of CBDV in the treatment of Parkinson’s disease

March 26, 2023 from Magazin Konopi

Cannabidivarin (CBDV) is a structural analogue of CBD and has gained attention in recent years due to its anticonvulsant (ie seizure-reducing) properties and potential in the treatment of autism spectrum disorders.

This time, a team of Chinese scientists investigated this phytocannabinoid in connection with Parkinson’s disease. They chose Caenorhabditis elegans , i.e. the common nematode , as a model organism. They published the results in the FASEB Journal.

Leave your thoughts

EUCannaJobs is the leading cannabis industry job board. Browse cannabis-related jobs found at the dispensaries, doctors’ offices, cultivation centers, delivery services, manufacturing, packaging, marketing and more!

Contact Us